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Abbreviations 
Å Angstrom 
Ac Acetyl 
Ac2O Acetic anhydride 
ACN Acetonitrile 
Allyl Allyl ether 
Boc Tert-butoxycarbonyl 
CH2Cl2 Dichloromethane 
CN Coordination number 
Cyclen 1,4,7,10-tetraazacyclododecane 
DCC N,N’-dicyclohexylcarbodiimide 
DEDTC Diethyldithiocarbamate 
DIEA N,N’-diisopropylethylamine 
DMF Dimethylformamide 
DOTA 
1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetate 
DOTAM 
1,4,7,10-tetrakis(carbamoilmethyl)-
1,4,7,10-tetraazacyclododecane 
ESI Electrospray ionization 
Fmoc 9-fluorenylmethoxycarbonyl 
HATU 
1-[Bis(dimethylamino)methylene]-1H-1,2,3-
triazolo[4,5-b]pyridinium 3-oxid 
hexafluorophosphate 
HF Fluorhydric acid 
HOBt 1-hydroxybenzotriazole 
HPLC High Performance Liquid Chromatography 
MeOH 
MPLC 
Methanol 
Medium Pressure Liquid Chromatography 
MS Mass Spectrometry 
NMM N-methylmorpholine 
NMR Nuclear Magnetic Resonance 
Pd(OAc)2 Palladium acetate 
PhSiH3 Phenylsilane 
PPh3 Triphenylphosphine 
rt Room temperature 
SPPS Solid Phase Peptide Synthesis 
tBu Tert-butyl 
TFA Trifluoroacetic acid 
TIS Triisopropylsilane 
TNBS 2,4,6-trinitrobenzenesulfonic acid 
tR Retention time 
δ Chemical shift 
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Abstract 
Nitration of tyrosine residues of proteins has been found to be related to the onset 
and the progression of neurodegenerative diseases such as Parkinson’s. In cells, this 
protein modification is mediated by peroxynitrite, which is produced under oxidative 
stress conditions. The aim of this work is the design and synthesis of a luminescent 
sensor for oxidative stress. The basis is to use a lanthanide-peptide complex whose 
luminescence signal will increase under oxidative stress conditions, by using the 
generated 3-nitrotyrosine chromophore as lanthanide sensitizer. 
Thus, two peptides, having the same sequence but one of them containing a 
nitrated tyrosine residue, were synthesized following standard Fmoc solid phase peptide 
synthesis protocols. In addition, two different DOTA derivative ligands were synthesized 
following stablished synthetic methodologies, and those were coupled to the peptides 
at an orthogonally deprotected Glu residue side chain, while the peptides are still 
attached to the solid support. The expected products were obtained, although without 
full completion of the reaction. 
HPLC-MS and NMR were the techniques used in order to characterize the products 
and to follow the reactions. 
Keywords: lanthanides, solid phase peptide synthesis, coordination chemistry, 
luminescence. 
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Resumen 
La nitración de residuos de tirosina en proteínas está relacionada con el inicio y la 
progresión de enfermedades neurodegenerativas como el Parkinson. En las células, esta 
modificación de las proteínas es producida por moléculas de peroxinitrito, que se 
generan en condiciones de estrés oxidativo. El objetivo de este trabajo es el diseño y 
síntesis de un sensor luminiscente de estrés oxidativo. La base es usar un complejo 
péptido-lantánido cuya señal de luminiscencia aumentará en condiciones de estrés 
oxidativo, al utilizar el cromóforo 3-nitrotirosina generado como sensibilizador del 
lantánido. 
Por lo tanto, se sintetizaron dos péptidos, que tienen la misma secuencia pero uno 
de ellos contiene un residuo de tirosina nitrado, siguiendo protocolos habituales de 
síntesis de péptidos en fase sólida utilizando la estrategia Fmoc. Además, se sintetizaron 
dos ligandos derivados del DOTA, siguiendo metodologías sintéticas establecidas, y 
estos se acoplaron a los péptidos en la cadena lateral de un residuo de Glu 
ortogonalmente desprotegida, mientras los péptidos todavía están unidos al soporte 
sólido. Se obtuvieron los productos esperados, pero sin producirse la conversión total 
de los productos de partida. 
HPLC-MS y RMN fueron las técnicas utilizadas para caracterizar los productos y 
seguir las reacciones. 
Palabras clave: lantánidos, síntesis de péptidos en fase sólida, química de 
coordinación, luminiscencia.  
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Resumo 
A nitración de residuos de tirosina en proteínas está relacionada co inicio e a progresión 
de enfermidades neurodexenerativas como o Parkinson. Nas células, esta modificación 
das proteínas é producida por moléculas de peroxinitrito, que se xeran en condicións de 
estrés oxidativo. O obxectivo deste traballo é o deseño e síntese dun sensor 
luminescente de estrés oxidativo. A base é usar un complexo péptido-lantánido cuxa 
sinal de luminescencia aumentará en condicións de estrés oxidativo, ao utilizar o 
cromóforo 3-nitrotirosina xerado como sensibilizador do lantánido. 
Polo tanto, sintetizáronse dous péptidos, que teñen a mesma secuencia pero un 
deles contén un residuo de tirosina nitrado, seguindo protocolos habituais de síntese de 
péptidos en fase sólida utilizando a estratexia Fmoc. Ademais, sintetizáronse dous 
ligandos derivados do DOTA, seguindo metodoloxías sintéticas establecidas, e estes 
acopláronse aos péptidos na cadea lateral dun residuo de Glu ortogonalmente 
desprotexida, mentres os péptidos aínda están unidos ao soporte sólido. Obtivéronse 
os produtos esperados pero sen producirse a total conversión dos produtos de partida. 
HPLC-MS e RMN foron as técnicas utilizadas para caracterizar os produtos e seguir 
as reaccións. 
Palabras chave: lantánidos, síntese de péptidos en fase sólida, química de 
coordinación, luminiscencia.  
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Neurodegenerative Diseases and Oxidative Stress 
Neurodegenerative diseases are characterized by a progressive dysfunction of the 
nervous system. These disorders are usually associated with the atrophy of the affected 
central or peripheral structures, including diseases such as Parkinson's, Alzheimer's and 
other dementias, as well as diseases caused by prions, among many others. In 2009, the 
European Union estimated that 7 million European citizens had developed this type of 
diseases, and that the treatment and care of these patients cost the European health 
services approximately 130.000 million euros only in 2005. As a consequence of the 
aging of European population, these data are expected to increase considerably in the 
coming decades. The existing treatments for neurodegenerative diseases are limited, 
and mainly treat the symptoms instead of treating their causes. 
Parkinson's disease is the second most common neurodegenerative disorder and 
affects 2-3% of the population over 65 years of age. Its neuropathological characteristics 
include neuronal loss in specific areas of the brain, accompanied by insoluble aggregates 
of the α-synuclein protein.1–3 The underlying molecular pathogenesis involves multiple 
pathways and mechanisms such as α-synuclein proteostasis, mitochondrial function or 
oxidative stress among others. 
Oxidative stress is produced due to a disturbance in the balance between the 
concentration of reactive oxygen species (free radicals) and antioxidant defenses, which 
may cause protein damage and tissue injury. The most common free radicals present in 
biological environments include the hydroxyl radical (•OH), superoxide anion (O2•−), 
transition metals such as iron and copper, nitric oxide (NO•), and peroxynitrite 
(ONOO−)4; the latest of these playing a crucial role in biomolecule nitration.4 
Peroxynitrite is a strong nitrating agent formed primarily by the reaction between 
the two radicals nitric oxide (NO•) and superoxide (O2•−) in biological environments. The 
most representative process mediated by peroxynitrite is the nitration of tyrosine (3-
nitrotyrosine), which is defined as the substitution of a hydrogen in the ortho-position 
of the phenolic ring by a nitro group, either in free or coupled tyrosine.5  
Several studies have identified accumulations of α-synuclein protein with nitrated 
tyrosine residues in the characteristic inclusions of Parkinson's disease (Lewy bodies), 
evidencing a clear connection between oxidative and nitrative damage with the onset 
and the progression of neurodegenerative synucleinopathies.6 
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PROTEINS AND PEPTIDES 
PEPTIDE BOND AND PROTEIN STRUCTURE 
Peptides and proteins are biopolymers whose monomer units are α-amino acids bound 
each other by an amide bond (also known as peptide bond). α-amino acids are 
characterized for having an amine group in the α position of a carboxylic acid group, and 
follow the general formula of H2NCH(R)COOH. In order to form peptides, repeated 
reactions of one carboxylic acid group of one amino acid with the amine group of 
another occur to give a chain of amides formed by condensation.7 
 
          Apolar side chains                       Polar side chains        Charged side chains                                    
  
Figure 1. Peptide bond formation by condensation of a carboxylic acid and an amine. Structure and 
codes of one and three letters for the most common amino acids. 
 
Introduction 
 
 
13 
All of these amino acids belong to the L series; therefore, they have the same 
stereochemistry. Depending on the side chain (R group), amino acids can be classified 
into three main groups: apolar (G, A, V, L, I, M, F, P, W), polar (S, T, N, Q, Y, C) and charged 
ones, which can be acidic (D, E) or basic (K, R, H). 
It should be mentioned that a peptide bond can be represented as two resonance 
isomers (Figure 2). This means that the actual peptide bond is a resonance hybrid of 
these two isomer structures, which makes the C-N bond having a 50% of double bond 
character. The consequence of this is that rotation mainly occurs between Cα–C and N–
Cα bonds meaning that the adjacent peptide planes (see Figure 3)8 can rotate with 
respect to each other.9 
 
Figure 2. Electronic isomer structure of a peptide bond. 
 
Figure 3. Representation of the repeating amino acid units of a polypeptide chain with alternating rigid 
amide (green) and α-carbon planes linked by rotating ψ and ϕ bonds.8 
However, the idea of amino acids bonded together in a flat two-dimensional model 
for a polypeptide chain does not describe adequately the reality of a three-dimensional 
arrangement, which bears the structure of a protein. In fact, it is this complicated folding 
structure, which gives proteins their characteristic functional properties. 
When describing the three-dimensional structure of proteins, all levels of 
organization should be considered. Primary structure refers to the linear sequence of 
amino acid residues along the polypeptide chain. Every protein is defined by a unique 
linear order of residues and all subsequent levels of arrangement rely on this primary 
level of structure.10 
Rather than an extended configuration of a polypeptide chain, most proteins are 
present in a compact globular form, whose interior is a strongly hydrophobic 
environment. This may be a problem since polypeptides have polar groups capable of 
forming hydrogen bonds by the C=O and N-H groups and they cannot bond with the side 
chain hydrophobic groups of the molecule. Therefore, in order to bear a stable 
conformation, the backbone groups will bond with the same or an adjacent polypeptide 
backbone, arising the secondary structure. 
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There are two main types of secondary structures, the α-helix and the β-pleated 
sheet (Figure 4)11. In the first one, the polypeptide backbone twists into a right-handed 
helix in which 3.6 amino acids units are needed to perform a turn (this was deduced by 
Linus Pauling in 1951). This results in the C=O of each peptide bond to form a hydrogen 
bond with the N-H group of the fourth consecutive amino acid, forming a cylindrical 
structure. Meanwhile, in the β-pleated sheet, the backbone groups form a hydrogen 
bond to groups of an adjacent one; thus, giving the possibility to several polypeptide 
chains to form a single sheet. The adjacent polypeptide chain can be bonded in a parallel 
or in a antiparallel manner depending on the alignment of the hydrogen bonds.12 
 
 
 
 
 
 
 
 
Figure 4. Left: Representation of an α-helix structure with the representation of its hydrogen bonds. Right: 
a parallel plot of a β-plated sheet with the representation of its hydrogen bonds.11 
The tertiary structure refers to the folded polypeptide chain and represents the 
overall topology of the spatial arrangement of the amino acids along the polypeptide 
chain. The folding comes from the joining of the secondary structure, giving place to a 
compact globular molecule via interactions such as hydrogen bods, disulphide bridges, 
electrostatic interactions, and Van der Waals forces. For proteins longer than 150 amino 
acid units, the tertiary structure may be organized around more than one domain, which 
are structural units within the tertiary structure.10 
 
Figure 5. Example of a protein tertiary structure, which shows two domains of a subunit of a dimeric 
protein. 
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Finally, many proteins develop a higher organization degree and are made up of 
several protein monomers (which have their own primary, secondary and tertiary 
structures). This arrangement of subunits, leads to a functional complex known as the 
quaternary structure.12  
SOLID PHASE PEPTIDE SYNTHESIS 
Solid phase peptide synthesis (SPPS) was introduced by Merrifield in 1963. Since 
then, the chemistry related with this technique has developed dramatically, with 
improvements in the resins, protecting groups and methods of coupling and 
deprotection used during the synthesis. However, the basic synthetic tactics remain 
almost the same as those outlined by R.B. Merrifield more than five decades ago.13 
The solid support used in this technique must be insoluble and should bear a linker 
with an appropriate functional group at which the first amino acid is attached. The 
stepwise SPPS usually proceeds in the C → N direction, so the linker must incorporate a 
functional group that reacts with the C-terminus of the first amino acid, conveniently 
protected at its N-terminus. Therefore, the synthesis proceeds by selective removal of 
the temporally amine protecting group of the first amino acid, followed by the coupling 
of the second, properly protected, amino acid. The coupling cycle continues until the 
peptide sequence has the desired length.14 
Scheme 1. Representation of the Solid Phase Peptide Synthesis steps. 
In peptide chemistry, a crucial issue for the synthesis of these polyfunctional 
molecules is the protection of their functional groups, since peptides can contain up to 
eight distinct functional groups in addition to indole and imidazole rings, which should 
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be also protected.15 Therefore there are two main methods for peptide synthesis, which 
are classified depending on the protecting strategy used: Boc/Bn or Fmoc/t-Bu. 
The Boc/Bn methodology uses tert-butylcarbonyl (Boc) as protecting group for the 
α-amino functionality of amino acids. The most common removal conditions for Boc are 
25-50% TFA in DCM. Meanwhile, benzyl (Bn) group protects side chains of the amino 
acids, and it is generally removed with hydrofluoric acid, which is extremely dangerous. 
On the other side, the Fmoc/t-Bu methodology uses 9-fluorenylmethoxycarbonyl 
(Fmoc) to protect the α-amino group and mild bases, mainly secondary amines such as 
piperidine in DMF, remove it. The t-Bu group protects the side chains and its removal is 
performed with TFA in the final step when the bond between the peptide and the solid 
support is also cleaved.15 
 
Figure 6. Cleavage of protecting groups from the different strategies in SPPS. 
The key step in the peptide synthesis is the coupling between two amino acids, 
which involves the attack by the amino group of one residue at the carbonyl carbon of 
the carboxyl group, which has to be activated by the introduction of an electron 
withdrawing group.16 Nowadays, there are four main ways to perform the activation: 
a) Carbodiimides: they are one of the most widespread activating agents. Their 
main limitation is that they can produce dehydration of Asn and Gln residues, which can 
be avoided by the addition of HOBt to the reaction mixture. N,N´-dicyclohexyl derivative 
(DCC) is the most used carboiimide.14 
 
b) Mixed Carbonic Anhydrides: they are formed by reaction of an α-N-protected 
amino acid with alkyl chloroformates. The major advantages of this method are its 
simplicity and the high yields and purity of peptides obtained. However, a major 
drawback is racemization due to the highly activation of the carboxyl carbonyl that could 
lead to the oxazolone formation.13 
c) Active Esters: they are generally formed by adding a trapping agent into a mixture 
of an α-N protected amino acid and DCC; therefore they may be considered somewhat 
into the carbodiimide method. Their major advantage is the formation of highly reactive 
amino acid esters which are capable of rapidly react with the amine of the other residue. 
The most common reagent is HOBt.13 
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Figure 7. Formation of an activated ester using HOBt. 
d) Phosphonium, aminium, and uronium salts: this method is the most important 
one, since it provides high purity of peptides and excellent yields even in difficult 
couplings. Uronium salts have been shown the ability to form activated species even in 
polar solvents, which has application in automated SPPS.13 
 
Figure 8. Most common phosphonium salts used as activating agents in SPPS 
Figure 9. Formation in situ of an activated ester and coupling with the polypeptide. 
LANTHANIDE IONS AND THEIR BEHAVIOR IN COORDINATION CHEMISTRY 
Lanthanides are those elements that follow lanthanum in the periodic table, from 
cerium to lutetium, making a homogenous group with a total of fourteen elements. They 
show a high uniformity in their chemical properties, behaving as electropositive metals 
that have a strong preference to the trivalent oxidation state. 
The reason for the occurrence of the trivalent oxidation state in the lanthanide ions, 
Ln(III), is given by the relative energies of the electronic orbitals 4f, 5d, 6p and 5s along 
the fourteen different elements, from Z=57 to 71 (Table 1). The enthalpy balance of the 
atomization, ionization and hydration enthalpies determines that the trivalent state of 
the lanthanide ions is the most stable one occurring in aqueous solution across the 
whole lanthanide series. The hydration enthalpy increases along the series since the 
ionic radius decreases from La3+ to Lu3+. However, the redox potentials keep quite 
similar throughout the series, which at the beginning and the end of the series take the 
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values Eº(La3+/La) = -2.38 V and Eº(Lu3+/Lu) = -2.30 V. Thus, the increasing hydration 
enthalpies are compensated by higher ionization potentials on advancing along the 
series. The exception comes from the Ce4+, which is the only tetrapositive element with 
interest in aqueous solution. In acid solution it behaves as a stronger oxidant than 
chlorine, presenting the ability to remain in solution for long periods of time.17,18 The 
stabilization of the divalent oxidation states of Eu and Yb is related to the half-filled (4f7) 
and complete (4f14) occupation of the 4f shell in Eu2+ and Yb2+, respectively (Table 1). 
Table 1. Electronic configuration of the lanthanide ions and their respective cations. 
Atomic 
number 
Name Symbol Atom M2+ M3+ M4+ 
57 Lanthanum La 5d16s2 5d1 [Xe] - 
58 Cerium Ce 4f15d16s2 4f2 4f1 [Xe] 
59 Praseodymium Pr 4f36s2 4f3 4f2 4f1 
60 Neodymium Nd 4f46s2 4f4 4f3 4f2 
61 Promethium Pm 4f56s2 4f5 4f4 - 
62 Samarium Sm 4f66s2 4f6 4f5 - 
63 Europium Eu 4f76s2 4f7 4f6 - 
64 Gadolinium Gd 4f75d16s2 4f75d1 4f7 - 
65 Terbium Tb 4f96s2 4f9 4f8 4f7 
66 Dysprosium Dy 4f106s2 4f10 4f9 4f8 
67 Holmium Ho 4f116s2 4f11 4f10 - 
68 Erbium Er 4f126s2 4f12 4f11 - 
69 Thulium Tm 4f136s2 4f13 4f12 - 
70 Ytterbium Yb 4f146s2 4f14 4f13 - 
71 Lutetium Lu 4f145d16s2 - 4f14 - 
The ionic radii of the Ln3+ ions decrease slightly with the increase in atomic number. 
Given their large ionic radii, the lanthanide ions generally form complexes with high 
coordination number and different coordination polyhedra. Their coordination number 
(CN) is usually 8 or 9, with some exceptions, while the coordination geometry is dictated 
by the topology and the steric effects caused by the ligands. Table 2 lists the effective 
ionic radii for the most common CNs of the lanthanide ions.18,19 
Table 2. Effective ionic radii for the Ln(III) ions. 
Cation CN 6 CN 8 CN 9 Cation CN 6 CN 8 CN 9 
La3+ 1.032 1.160 1.216 Tb3+ 0.923 1.040 1.095 
Ce3+ 1.01 1.143 1.196 Dy3+ 0.912 1.027 1.083 
Pr3+ 0.99 1.126 1.179 Ho3+ 0.901 1.015 1.072 
Nd3+ 0.983 1.109 1.163 Er3+ 0.890 1.004 1.062 
Pm3+ 0.97 1.093 1.144 Tm3+ 0.880 0.994 1.052 
Sm3+ 0.958 1.079 1.132 Yb3+ 0.868 0.985 1.042 
Eu3+ 0.947 1.066 1.120 Lu3+ 0.861 0.977 1.032 
Gd3+ 0.938 1.053 1.107     
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The Ln(III) ions are hard Lewis acids according to Pearson’s classification of hard and 
soft acids and bases. As a result, the Ln3+ ions have a strong preference to form 
thermodynamically stable complexes with ligands having hard donor atoms such as 
oxygen and nitrogen, particularly if they hold negative charges. In particular, the 
lanthanide ions form stable complexes with polyamino polycarboxylate-type ligands 
containing 8 or 9 potential donor atoms. For instance, the macrocycle 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA, Figure 10) forms 
thermodynamically stable complexes with Ln(III) ions that also present very slow 
dissociation kinetics.20 The coordination chemistry of DOTA and DOTA-derivatives with 
the Ln3+ ions has been extensively investigated, in part because of the application of the 
[Gd(DOTA)]- complex in clinical practice as a contrast agent in magnetic resonance 
imaging (MRI). DOTA-tetraamide derivatives such as DOTAM (Figure 10) were found to 
form complexes far less stable than DOTA, but they show slower dissociation kinetics.21 
Complexes of Eu3+ and Tb3+ with DOTA derivatives have been extensively investigated 
as luminescent probes.22 
 
Figure 10. Structure of the DOTA and DOTAM ligands. 
The complexes of DOTA and DOTAM with the lanthanide ions are eight-coordinated 
by the ligand, with a water molecule completing coordination number nine. The 
presence of this coordinated water molecule is essential for application of the Gd3+ 
complex as an MRI contrast agent, but it is detrimental for the luminescence efficiency 
of Eu3+ and Tb3+ derivatives. 
It should be mentioned that the mechanisms for the formation of DOTA and 
DOTAM complexes are different. While [Ln(DOTAM)]3+ complexes form in a direct 
reaction between the deprotonated DOTAM and the Ln3+ ion, in the case of DOTA, a 
diprotonated intermediate is formed by the coordination of the Ln3+ with the acetate 
groups of the deprotonated ligand. This intermediate experiences proton transfer from 
the nitrogen atoms of the macrocycle to the donor atoms of the acetate groups, so that 
the metal enters into the macrocyclic cage.23 
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LUMINESCENCE 
GENERAL CONCEPTS 
Fluorescence refers to a well-known phenomenon in which a photon is emitted 
from an excited molecule that relaxes to its ground state. Usually, fluorescence occurs 
if the transition takes place without change in the spin of the system, and thus generally 
involves emission from the first excited singlet state to the ground singlet state (S1→S0). 
Transitions implying a change in the spin of the system are the origin of 
phosphorescence, for instance arising from emission from the first excited triplet state 
to the ground singlet state (T1→S0). The 0–0 transition, which involves the lowest-energy 
vibrational states of the ground and excited levels, should present the same energy in 
the absorption and fluorescence spectra. However, the fluorescence spectrum is shifted 
to longer wavelengths (lower energy) with respect to the absorption spectrum due to 
the energy loss in the excited state by vibrational relaxation. The different processes 
that occur when a molecule absorbs a photon and reaches an exited state are 
represented in a Jablonski Diagram provided in Figure 11.24 
 
Figure 11. Jablonski diagram where the different processes that occur when a molecule absorbs a photon 
and jumps to an excited state. The molecule could also return to its ground state through a non-radiative 
relaxation process. ISC: Intersystem crossing; IC: Internal conversion.24 
The interactions of the molecule and its environment determine to a great extent 
several factors such as the lifetime of the excited state and the quantum yield of the 
emission process. The quantum yield refers to the ratio of emitted and excited photons, 
and is generally expressed as a percentage. 
Fluorescence probes have gained increasing attention in different research areas 
due to their specificity and sensitivity, along with the possibility to obtain spatial and 
time information with good resolution. Indeed, fluorescent probes allowed the 
development of techniques in biology that resulted in a dramatic improvement in the 
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comprehension of the structures and different phenomena of biomolecules. The design 
of fluorescent sensors has therefore a high demand for several clinical and biochemical 
applications. 
LANTHANIDE LUMINESCENT COMPLEXES 
Most of the lanthanide ions are found in their trivalent form (Ln+3), unlike transition 
metal elements, which possess a huge variety of oxidation states. The optical properties 
of Ln+3 ions present some relevant features associated to a great variety of electronic 
levels due to their [Xe]4fn configurations. Each level is defined by three quantum 
numbers, S, L, and J, within the framework of the Russel-Saunders spin-orbit coupling 
scheme. The energy of each of them is well defined since the 4f orbitals are shielded by 
the filled 5p66s2 subshells. Moreover, the energies of f-f transitions are not very affected 
by the chemical environment of the ion, due to the core nature of the 4f orbitals. 
Depending on the particular Ln3+ ion the 4f-4f transitions may be observed in the visible 
and near-infrared (NIR) regions, and they are easily recognizable because they are quite 
sharp (see Figure 12). The major advantage of these f-f transitions is that they are parity 
forbidden, which results in lifetimes of the excited states that are generally longer than 
in other ions and organic fluorophores. This makes the lanthanide ions quite useful in 
time-resolved detection and luminescence microscopy.25 
 
Figure 12. Luminescence spectra of some lanthanide tris(β-diketonates).25 
The major drawback of the lanthanide ions is that direct excitation of the 4f excited 
states is very inefficient, a problem related to the electric dipole selection rules, which 
forbid such transitions.26 Therefore, another approach has to be taken in order to 
improve the emission intensity. This is rather efficiently achieved by using the so called 
antenna effect, which relies on an indirect excitation as follows (Figure 13): 
1. The light is absorbed by an organic chromophore in the vicinity of the Ln+3 ion. 
 
2. Then the energy is transferred to the metal ion, which is excited to one or several 
excited states. 
 
3. Fluorescence emission is produced by relaxation of the metal that returns to its 
ground state. 
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Figure 13. Diagram showing the main energy flow paths during indirect excitation of lanthanide 
luminescence via the surroundings (ligands).16 
A lanthanide-based luminescent sensor should provide a selective change of the 
luminescent signal that is related to the concentration of the analyte. Ideally, the 
luminescent response should be such that the emission intensity is enhanced in the 
presence of the analyte. The modulation of Ln3+ luminescence can be achieved through 
three different mechanisms (see Figure 14): 
 
Figure 14. Representation of the different mechanisms operating in the modulation of lanthanide emission 
by reversible binding of an analyte. 
a) Acting directly on the Ln+3 ion, which provides a signal that depends on the 
chemical environment. For example, water molecules in the coordination sphere 
are well known to quench the emission of Ln3+ ions. Therefore, the replacement of 
coordinated water molecules by the analyte usually provokes an enhancement of 
the luminescent signal. 
Introduction 
 
 
23 
b) Another approach consists in modifying the photophysical properties of the 
ligand when the analyte is attached, for instance intra- or inter-molecular 
quenching of the ligand-centered singlet or triplet states. 
c) Lastly, the analyte may also play the role of acting as a sensitizer of the Ln+3 ion 
or even as a quencher. 
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The use of lanthanide luminescence is an attractive strategy for the detection and 
monitoring of biological activity in cells, since luminescence provides a reliable, sensitive 
and non-invasive technique for the following of such processes. Moreover, the long 
emission lifetimes of the Ln3+ ions allow time-resolved measurements that can be used 
to eliminate interferences from the luminescence of biomolecules.22 
In 2012, the group of M. E. Vázquez designed a Eu3+ peptide complex whose 
luminescence signal is modulated by the phosphorylation state of a serine residue 
incorporated in the peptide sequence, in such way that the probe can monitor the 
enzymatic activity of both protein kinase C (PKC) and alkaline phosphatase (AP). The 
heptadentate DO3A (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) macrocyclic 
ligand does not satisfy all the coordination sites of the metal ion, which contains one 
coordinated water molecule. However, an external antenna can fill this position 
providing a highly emissive complex. However, when the serine residue is 
phosphorylated by PKC, the phosphate group coordinates the metal and displaces the 
antenna from the coordination sphere, promoting a decrease of the emission intensity. 
Addition of AP over the phosphorylated probe in the presence of the external antenna 
restores the emission of the Eu(III) complex due to the dephosphorilation of the serine 
residue (Figure 15).27,28  
 
Figure 15. Proposed mechanism for the generation of a luminescence signal with the added coordination 
antenna to excite the lanthanide ion.28 
A more recent example published in 2015, showed that terbium complexes are 
useful for monitoring the activity of NAD(P)H-dependent enzymes. In this case, the 
authors reported a terbium (III) complex with a 1,4,7,10-tetraazacyclododecane 
functionalized with amide ligands and an azaxanthone antenna. The resulting 
luminescent complex has a +3 net charge that can electrostatically interact with NADH 
or NADPH molecules that are negatively charged (-2 and -4, respectively). This 
interaction promotes the quenching of the luminescence of the complex. Therefore, this 
system can be applied for monitoring the activity of NAD(P)H dependent enzymes, such 
as lactate dehydrogenase. The addition of this enzyme over the Tb(III)complex-NADH 
mixture in presence of pyruvate, promotes the reduction of pyruvate to lactate and 
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transforms NADH in NAD+, destroying its interaction with the Tb(III) complex and 
therefore recovering its luminescence.29 
 
Figure 16. Left: Scheme of the interaction of a Tb(III) complex with NAD(P)H. Right: representation of the 
lactate dehydrogenase activity detection assay.29 
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The aim of this work is to develop an optical sensor, based on the luminescence of 
lanthanide ions, for the detection of nitro-oxidative stress in cells. The design relies on 
the incorporation of a Ln3+ chelate in a peptide sequence derived from α-synuclein, 
known to be nitrated in vitro and in vivo, allowing to use the generated 3-nitrotyrosine 
chromophore as lanthanide sensitizer. 
The ligands chosen for this project were designed to provide coordinatively 
unsaturated Ln3+ complexes, so that water molecules are expected to complete the 
metal coordination environment in aqueous solution. These water molecules should 
quench the excited state of the Ln3+ ion through vibrational deactivation. The change of 
the pKa of the hydroxyl group with respect to tyrosine upon nitration of the peptide (≈7 
and ≈10 respectively) may result in a partial deprotonation of the phenol group at 
physiological pH. We hope that this will trigger the coordination of the phenolate group 
to the Ln3+ ion, causing the displacement of the coordinated water molecules. This 
would generate a complex with higher luminescence promoted both by the shorter 
distance between the antenna and the metallic centre, and by the displacement of 
water molecules from the inner-coordination sphere of the metal ion. Thus, in this work 
we wanted to perform some preliminary work towards the aim of developing a sensor 
of oxidative stress (Figure 17). More specifically, this work aimed at: 
1. Synthesis of two peptide sequences, one of them containing a tyrosine 
residue and the other a 3-nitrotyrosine residue. 
2. Synthesis of the macrocyclic ligand modified with an amine group, so that 
it can be coupled to the peptide. 
3. Coupling between the lanthanide chelate and both peptides. 
Subsequent studies will complete this work by studying the coordination of the 
lanthanide ion by the modified peptides, studying the luminescent properties of both 
lanthanide-peptide complexes, and the assessment of the potential use of  
3-nitrotyrosine as lanthanide sensitizer. 
 
Figure 17. Scheme of the proposed sensor and its mechanism for giving a luminescent response upon 
oxidative stress. 
While being a scientific work, it should be pointed out that the work carried out 
during this Final Degree Project involves also a strong pedagogical component. The work 
carried out in this project contributed to strengthen and develop different skills and 
competences related to the bachelor degree in chemistry. Among the competences 
developed during this work are:  
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Learning outcomes Degree competences 
To understand the concepts, methods 
and results of the major areas of 
chemistry. 
 
A1, A14, B3, C2, C8 
To be able to interpret data, information 
and relevant results, obtaining 
conclusions and make thoughtful reports 
about scientific problems. To work, learn 
and research resources independently. 
 
A16, A24, B2, B4, C1, C2, C3, C4, C6 
To be able to apply theoretical knowledge 
along with practical skills that have been 
acquired during the degree and proposed 
solutions related to the academic or 
professional field. 
 
 
B2, B3, B4, B5, B6, C4, C6 
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PEPTIDES DESIGN AND SYNTHESIS  
PEPTIDE DESIGN 
The design of the sensor was accomplished by selecting sequences of α-synuclein 
that have been found nitrated both in vitro and in vivo.30 Specifically, we sought to 
modify the 36GVLYVGSKT44 fragment by adding: 1) a Pro residue at its N-terminus, since 
Pro-Gly is a β-turn inducing sequence that could preorganize the peptide chain to favor 
the complexation of the antenna, and 2) a Glu residue to which the metal complex will 
be conjugated in its side chain. Therefore, based in this sequence, we designed two 
peptides (Figure 18) differing only in the tyrosine residue. In the case of P1 the tyrosine 
residue is not modified and in the case of P2 this residue is nitrated (3-nitrotyrosine). 
 
Figure 18. Structure of the designed P1 and P2 peptides. 
As for the lanthanide binding unit, we have chosen a chelator based on a DO3A 
scaffold (Figure 18, DO3A = 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid). The 
heptadentate DO3A unit is known to form rather stable complexes with the Ln3+ ions, 
combined with relatively slow dissociation kinetics. Furthermore, the [Ln(DO3A)] 
complex is coordinatively unsaturated, and contains two water molecules bound to the 
metal center. These complexes are also known to bind reversibly different anions, and 
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therefore the [Ln(DO3A)] motif appears to be a good choice for the envisaged 
application. 
PEPTIDE SYNTHESIS  
 
Scheme 2. General synthetic strategy for P1 and P2 synthesis (in this case only P1 is shown). 
The peptides were synthesized using standard solid phase peptide synthesis 
protocols following the the Fmoc/t-Bu strategy. All the couplings were efficiently 
performed and there was no need of recoupling any amino acid (Scheme 2). 
From the chosen sequence, residues Thr, Ser and Tyr all have their side chain –OH 
group protected with tert-butyl units, while the side chain of Lys has its functional group 
protected with a Boc group. All of them can be efficiently removed by TFA, which also 
cleaves the peptide chain from the resin. The Glu residue has its side chain protected 
with an allyl group, which is removed through palladium catalysis. 
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Figure 19. Structure of the designed P1 and P2 peptides attached to the solid support. The protecting 
groups of the side chains are highlighted in red, along with the reagents used in order to remove them and 
to cleave the peptides from the solid support. 
Once all couplings were performed, and before the removal of the Allyl group, the 
peptides were cleaved from the resin and analyzed by reverse phase HPLC-MS in order 
to check whether the peptide synthesis was successful. For peptide P1, the HPLC 
chromatogram (Figure 20) presents a mayor peak at tr = 16.4 min that was identified by 
ESI-MS as the desired product (m/z = 1230.5, Figure 20). 
  
Figure 20. HPLC chromatogram of the reaction crude in which the peak at tr = 16.4 min corresponds to 
P1. ESI-MS of the HPLC peak at tr = 16.4 min. 
In the case of P2, a mayor peak in the HPLC chromatogram (Figure 21) at tr = 17.4 
min was identified as the expected nitrated peptide, as confirmed by the presence of a 
major signal at m/z = 1275.4 corresponding to the desired peptide protected with the 
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allyl group. Hence, after corroborating the formation of both P1 and P2 peptides the 
following step (removal of the allyl group) was performed. 
 
Figure 21. HPLC chromatogram of the reaction crude in which the peak at tr = 17.4 min corresponds to 
P2. ESI-MS of the HPLC peak at tr = 17.4 min. 
ALLYL GROUP DEPROTECTION 
Since the coupling of the DO3A fragment requires the condensation of the amine 
group present in the macrocycle and the carboxylic acid of the Glu side chain, while the 
peptide is attached to the solid support, we chose an allyl unit as orthogonal protecting 
group for the Glu side chain. This group can be selectively removed by catalytic 
treatment with Pd affording the desired carboxylic acid without affecting any of the 
other amino acid protecting groups. The mechanism is described below (Scheme3); the 
final nucleophilic attack was carried out using triphenylsilane and N-methylmorpholine. 
 
Scheme 3. Mechanism for the deprotection of the allyl group.  
The analyses by HPLC-MS of a small portion of each resin confirmed the 
deprotection of the Glu side chain, obtaining a peak at tr = 11,4 min corresponding to P1 
(m/z = 1190.6, Figure 22) and a peak at tr = 12.3 min corresponding to the nitrated 
peptide P2 (m/z = 1235.7, Figure 23). 
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Figure 22. HPLC chromatogram of the reaction crude in which the peak at tr = 11,4 min corresponds to 
P1 without the allyl group. ESI-MS of the HPLC peak at tr = 11,4 min. 
 
 
Figure 23. HPLC chromatogram of the reaction crude in which the peak at tr = 12.3 min corresponds to 
P2 without the allyl group. ESI-MS of the HPLC peak at tr = 12.3 min. 
SYNTHESIS OF LIGAND L1 
L1 was synthesized following the protocols described in literature (Scheme 4).31 
First, the commercially available DO3AtBu ligand was alkylated with N-Boc-2-
bromoethylamine through a nucleophilic substitution of the bromine by the secondary 
amine of the ligand. The corresponding product was characterized by ESI-MS (658.48 
m/z). The subsequent step was the deprotection of the carboxylic acid groups, along 
with the removal of the Boc protecting group of the amine, by treatment with TFA. The 
obtention of the desired product was confirmed by ESI-MS (390.23 m/z). The 1H NMR 
spectrum recorded in D2O solution presents broad signals in the range 2.5-4.5 ppm, a 
feature that is characteristic of DO3A derivatives. The 13C NMR spectrum was more 
informative, showing two broad signals due to the carbonyl groups at 175.1 and 170.1 
ppm, together with a sharper resonance at 174.4. This suggests a relatively high degree 
of rigidity of the macrocycle. The aliphatic region shows up to 13 signals, which points 
to a C1 symmetry of the ligand in D2O solution. The spectrum also shows two quadruplets 
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at 162.8 ppm (2JC-F = 35.5 Hz) and 114.9 ppm (1JC-F = 292 Hz) due to TFA, which indicates 
that the L1 ligand was isolated as the trifluoroacetate salt. 
 
 
Scheme 4. Synthetic route followed for the synthesis of ligand L1. 
COUPLING OF LIGAND L1 TO PEPTIDES P1 AND P2 
The coupling of L1 to the deprotected carboxylic acid side chain of the Glu residue 
of both peptides P1 and P2 was carried out with the peptides still attached to the solid 
support. The method used for the coupling of the ligands was the activation of the 
carboxylic group by the in situ formation of the activated ester with HATU, which reacts 
with the amine group present in L1.  
After performing the coupling, a small portion of each resin was analyzed by HPLC-
MS (Figure 24). For P1 the HPLC chromatogram shows three peaks, in which the peak at 
tr = 10.9 min was identified by ESI-MS as the desired peptide with L1 attached, the peak 
at tr = 11.4 min was identified by ESI-MS as the unmodified peptide, and the peak at tr = 
12.3 min was identified by ESI-MS as the unmodified peptide in which the free carboxylic 
acid experienced an intramolecular condensation to form an unreactive lactam. The 
HPLC chromatogram obtained indicates that the desired peptide coupled to the DO3A 
unit was obtained as a minor product, with the unreacted peptide and that resulting 
from lactam formation giving more intense peaks. 
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Peak tR (min) MS (m/z) Assignment 
A 10.9 782.0 [MH2]2+ Product 
B 11.4 1190.6 [MH]+ P1 
C 12.3 1172.5 [MH]+ P1 (-H2O) 
Figure 24. HPLC chromatogram of the coupling between L1 ligand and P1 with each peak analysed by 
mass spectrometry. 
In the case of P2 the HPLC chromatogram (figure 25) showed many peaks. However, 
despite this, the peak at tr = 11.6 min could be identified by ESI-MS as the desired 
product and the peak at tr = 12.3 min could be identified by ESI-MS as the unmodified 
peptide P2. 
 
Peak tR MS (m/z) Assignment 
A 11.6 804.5 [MH2]2+ Product 
B 12.3 1235.4 [MH]+ P2 
Figure 25. HPLC chromatogram of the coupling between P2 and L1 ligand with each peak analyzed by 
mass spectrometry. 
After analyzing the obtained results, the coupling was performed using the less 
reactive coupling agent HBTU, but the results obtained in these cases did not improved 
the ones just described for HATU.  
As an alternative to improve the coupling of L1 to P1 and P2, we attempted to 
obtain the EuL1 complex, hoping that the complex could be more efficiently coupled to 
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the peptide. Thus, we reacted the L1 ligand with different Eu3+ salts (EuCl3 and Eu(OTf)3), 
using different bases to ensure the deprotonation of the carboxylate groups (Et3N, 
K2CO3) and solvents (water and 2-propanol). The complexation reaction was followed by 
ESI-MS by taking aliquots of the reaction mixture and analyzing them at different 
reaction times. Unfortunately, these analyses revealed an intense peak corresponding 
to the protonated ligand L1 with m/z = 390.2, which dominated the MS even after 
prolonged reaction times (up to 10 days). The peak corresponding to the protonated 
complex (m/z = 540.1) was only observed as a minor peak, which indicated that complex 
formation was not efficient. We do not have a definitive explanation for the lack of 
reactivity of the ligand, but it could be related to very slow complexation kinetics (as 
observed for DOTA-like ligands in some cases), or perhaps because of a hydrogen-
bonding interaction involving the protonated amine of the side chain and the negatively 
charged carboxylate groups. This interaction occurring on the side of the macrocycle 
through which the Ln3+ ion should enter the cavity of the macrocycle might block the 
entrance of the metal ion, resulting in very slow complexation kinetics. 
SYNTHESIS OF LIGAND L2 
 
Figure 26. Comparison of the structures of ligands L1 and L2. 
The synthetic protocol followed for ligand L2 was similar to that used for the 
synthesis of L132. The starting compound was also DO3AtBu, which was alkylated in the 
secondary amine of cyclen with 4-nitrobenzenylbromide through a nucleophilic 
substitution, with a reaction yield of 73%. This intermediate presents the characteristic 
intense stretching (C=O) vibration of the carbonyl groups at 1712 cm-1. The presence 
of an absorption at 1345 cm-1 due to the symmetric stretching vibration of the nitro 
group (1265-1390 cm-1), and a second band at 1521 cm-1 due to the asymmetric 
stretching of the same group (1495-1580 cm-1)33, confirm the successful alkylation of the 
DO3A unit. The next step was the reduction of the nitro group with H2 under Pd/C 
catalysis to obtain the corresponding amine.33 Both compounds (nitro and amino 
derivative) where characterized by ESI-MS along with 1H- and 13C-NMR. The ESI-MS of 
the final product shows an intense peak (100% BPI) at m/z = 620.4 due to the 
(protonated) desired product, together with a second peak (30% BPI) at m/z = 642.4 
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due to the [NaL2]+ entity. This result confirms that both the alkylation of DO3AtBu and 
the reduction of the nitro group were successful. The 1H-NMR spectrum presents two 
doublets at 7.12 and 6.57 ppm (3J = 8.4 Hz) attributed to the aromatic protons of the 
aminobenzyl group. The spectrum also shows intense signals at 1.41 and 1.39 ppm due 
to the tertbutyl groups. The signals due to the aliphatic CH2 protons are observed as 
relatively broad and poorly defined signals in the range 2.0-4.0 ppm. This is a rather 
typical behavior observed for cyclen-based ligands, which is related to the 
conformational rigidity of the macrocyclic scaffold. We also notice that the 1H-NMR 
spectrum presents two additional doublets in the aromatic region that indicate the 
presence of a second species with an abundance of 14%. However, these signals likely 
correspond to a protonated form of the ligand, as suggested by the presence of a broad 
signal at 9.84 ppm attributable to a proton inside the macrocyclic cage. 
 
Scheme 5. Synthetic route for the ligand L2. 
COUPLING OF THE LIGAND L2 TO THE PEPTIDES P1 AND P2 
The coupling of L2 to the deprotected carboxylic acid side chain of the Glu residue 
of both peptides P1 and P2 was carried out in the same way as in the case of L1, except 
for the fact that in this case the ligand was coupled without previous hydrolysis of the 
tert-butyl groups. This strategy allows minimizing potential side reaction affecting the 
carboxylate groups of the DO3A unit. The tert-butyl groups can be easily removed with 
the TFA treatment used to cleave the peptide from the resin. The method used for the 
coupling of the ligand was the activation of the carboxylic group by the in situ formation 
of the activated ester with HBTU, which reacts with the amine group present in L2.  
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After performing the coupling, a small portion of each resin was analyzed by HPLC 
(Figure 27). Unfortunately, in these cases it has not been possible to analyze the samples 
by mass spectrometry, although analyzing the retention times the identity of the 
products can be qualitatively assigned.  
For P1 the HPLC chromatogram shows four peaks in which the peak at tr = 10.9 min 
(A), as it has been observed for L1, can be assigned to L2 attached to the peptide, the 
peak at tr = 11.4 min (B) can be identified as the unmodified peptide, and the peak at tr 
= 12.3 min can correspond to the unmodified peptide in which the free carboxylic acid 
experienced an intramolecular condensation to form an unreactive lactam (C). Finally, 
there is a fourth peak at tr = 13.8 min that may be related with uncomplete t-Bu removal 
by TFA treatment during the cleavage of the peptide from the solid support. The HPLC 
chromatogram obtained indicates that the desired peptide coupled to L2 was obtained 
as secondary product. 
 
Peak tR (min) Assignment 
A 10.9 Product 
B 11.4 P1 
C 12.3 P1 (-H2O) 
D 13.8 Unhydrolized product 
Figure 27. HPLC chromatogram of the coupling between P1 and L2.. 
For the coupling with P2, the HPLC chromatogram shows four major peaks, in which 
the peak with at tR = 11.6 min (A) matches with the expected value for the desired 
product, the one at tR = 12.3 min surely corresponds with P2 without L2 ligand (B), and 
the peaks at tR = 13.4 min and tR = 14.5 min may be related with the uncomplete t-Bu 
removal. Thus, while incomplete, the analysis of the HPLC chromatograms confirms the 
coupling of L2 to the envisaged peptides. 
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  Peak tR Assignment 
A 11.6 Product 
B 12.3 P2 
C 13.4 Unhydrolized product 
D 14.5  
Figure 28. HPLC chromatogram of the coupling between P2 and L2. 
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GENERAL INFORMATION 
CHARACTERIZATION TECHNIQUES 
Mass spectra for the characterization of the ligands and for the peptide-ligand 
couplings were obtained using electrospray ionization technique (positive mode) using 
a LC-Q-q-TOF Applied Biosystems QSTAR Elite mass spectrometer from the Research 
Support Services (SAI) from the Universidade da Coruña. 
For the performed 1H and 13C NMR analyses, a Nuclear Bruker AVANCE III HD 400 
belonging to the Research Support Services (SAI-UDC) was used, using CDCl3 and D2O as 
solvents for sample preparation. 
In order to obtain the IR spectrum, it was registered in a FT.IR spectrophotometer 
Nicolet iS-10 by Thermo Scientific, equipped with Thermo Scientific Smart iTR using the 
ATR (Attenuated Total Reflectance) technique, in the Advanced Scientific Research 
Center (CICA) from Universidade da Coruña. 
Reversed-phase HPLC-MS analyses were performed using a Thermo Scientific 
UltiMate 3000 instrument, which was connected to a single quadrupole mass 
spectrometer Thermo Scientific MSQ Plus, and to a PDA (Photo-Diode Array) detector. 
The solvents used were HPLC-MS quality solvents, A: 0.1% TFA, H2O and B: 0.1% TFA, 
ACN. The column used for these analyses was Phenomenex Aeris 3.6 μm peptide XB-C18 
100 Å; 150 × 2.1 mm. 
 
The gradient used for reversed-phase HPLC-MS experiments was set as following: 
 
Table 3. Gradient used for HPLC-MS experiments 
 
 
 
 
 
 
 
REAGENTS AND SOLVENTS 
The solvents used were synthesis grade, obtained from commercial resources, and 
were used with no additional purification steps. Water was purified using a Milli-Q 
system (Millipore). 
 
 
Time (min) Flow (mL/min) % B 
0 0.300 5 
2 0.300 5 
 25 0.300 95 
26 0.300 100 
32 0.300 100 
33 0.300 5 
40 0.300 5 
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Reagent Trading house 
DO3AtBu, pure CheMatech 
N-Boc-bromoethylamine, pure Carbosynth 
K2CO3, 99%* Sigma-Aldrich 
NaHCO3, 99%* Sigma-Aldrich 
Pd on activated charcoal 10% Sigma-Aldrich 
Fmoc standard amino acids Iris Biotech GmbH 
Triisopropylsilane, 98% Acros Organics 
N-methylmorpholine, 99% Acros Organics 
4-Methylpiperidine, 99% Acros Organics 
HATU Iris Biotech GmbH 
HBTU Iris Biotech GmbH 
HOBt Iris Biotech GmbH 
Triphenylphosphine, 99% Sigma-Aldrich 
Palladium (II) acetate, 99.98% Sigma-Aldrich 
DIEA, 99% Sigma-Aldrich 
TFA, peptide-synthesis grade Fisher Bioreagents 
*Previously dried in oven 
Solvent Trading House 
Acetonitrile, laboratory reagent grade Fisher Chemical 
MeOH, laboratory reagent grade Fisher Chemical 
Dichloromethane, laboratory reagent grade Fisher Chemical 
N,N-Dimethylformamide, peptide-syntheis grade Sigma-Aldrich 
SYNTHESIS 
PEPTIDE SYNTHESIS  
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• Resin: H-Rink amide ChemMatrix® resin (0.47 mmol/g) 
• Coupling reagent: HBTU/HOBt 0.2 M 
• Base: DIEA 0.195 M 
• TNBS protection/deprotection test for the amine group: 1 % TNBS/DMF + 10% 
DIEA/DMF 
• Fmoc removal agent: 4-methylpiperidine 
• Sequence: Glu-Pro-Gly-Val-Leu-Tyr-Val-Gly-Ser-Lys-Thr (Ac-EPGVLYVGSKT-NH2). 
First, the resin (0.1 mmol, 212.7 mg) was placed in a plastic column for SPPS and 
washed twice, one with DCM and the other one with DMF under N2 bubbling (Figure 
29A). Then, a TNBS test was done in order to check that the amine group was 
deprotected (positive result). The protected amino acid Fmoc-Thr(tBu)-OH (in excess, 4 
eq) was dissolved in 0.2 M HBTU/HOBt in DMF (4 eq, 2 mL) and then a 0.195 M DIEA 
solution in DMF (6 eq, 3 mL) was added. After 2 min mixing for the activation of the 
carboxylic acid, the solution was added to the resin and mixed under N2 bubbling for 30 
min. Afterwards, the solvent was removed by filtration (figure 29B), the resin was 
washed with DMF (2 × 5 mL), and then a TNBS test was performed to check the efficiency 
of the coupling, showing in this case a negative result. Finally, the Fmoc protecting group 
was removed by treatment with 20 % 4-methylpiperidine in DMF (in excess, 5 mL) during 
15 min. The resin was again filtered and washed three times, two with DCM and one 
with DMF, and then a TNBS test showed again positive result. This procedure was 
repeated for each amino acid of the peptide sequence, forming the peptide from the C-
terminus to the N-terminus. 
 
 
Figure 29. Assembly used for SPPS. 
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ALLYL GROUP DEPROTECTION 
 
The resin with the synthesized peptide (0.05 mmol, 61,5 mg) was treated with a 
mixture of Pd(OAc)2 (0.015 mmol, 3.4 mg), PPh3 (0.075 mmol, 19.7 mg), PhSiH3 (0.5 
mmol, 62 μL) and NMM (0.5 mmol, 55 μL) in DCM (2.5 mL), the solution was mixed 
overnight under mechanic stirring. Afterwards, the resin was filtered and washed as 
follow: DCM (2 × 2 mL × 2 min), DMF (2 × 2 mL × 2 min), DEDTC (25 mg/5 mL DMF × 15 
min), DMF (2 × 2 mL × 2 min), and DCM (2 × 2 mL × 2 min). 
L1 
 
In order to obtain L1, compound 1 (DO3AtBu) (0.97 mmol, 500 mg) and N-Boc-2-
bromoethylamine (0.97 mmol, 224 mg) were dissolved in 25 mL of ACN. Then, K2CO3 
(2.5 mmol, 335 mg) was added to the mixture and the solution was stirred under reflux 
for 17 h. Then, the solution was filtrated and the filtrate was concentrated to dryness 
under reduced pressure. A yellowish oil, identified as compound 2, was obtained (460 
mg, 72%).  
ESI-MS: m/z (l%) 658.5 (100%) [MH]+.  
Compound 2 was dissolved in 10 mL of TFA:CH2Cl2 (1:1) and the resulting mixture 
was stirred overnight. The solution was then concentrated under reduced pressure and 
washed with water several times. Compound 3 (L1) was obtained as a clear yellow solid 
after purification with reversed-phase MPLC (265.7 mg, 97.7%). The overall process yield 
was 70%.  
ESI-MS: m/z (l%) 390.3 (100%) [MH]+, 428.18 (41%) [MK]+ . 
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13C-NMR: (ppm) 174.37, 170.07, 66.08, 56.17, 53.03, 51.94, 50.46, 50.01, 49.14, 48.33, 
47.65, 42.22, 40.65, 36.19, 34.49 . 
 
P1-L1 COUPLING 
 
P1 resin (0.0084 mmol, 30 mg) was placed in an Eppendorf tube and 240 μL of DMF 
were added along with 0.195 M DIEA in DMF (0.0126 mmol, 64 μl) and HATU (0.0084 
mmol, 3.2 mg). The resulting mixture was mixed for 3 min for its activation, and then L1 
(0.042 mmol, 16.35 mg) was added and the mixture stirred for 1.5 h. Finally, the resin 
was filtered and washed with DCM (2 × 1 mL × 2 min).  
For the HPLC analysis, 3-4 mg of the resin were treated with 150 μL of the cleaving 
cocktail (2.5% triisopropylsilane, TIS, 2.5% H2O, and 95% TFA) for 1.5 h. Then, the resin 
was filtered, the filtrate was placed in ice-cold ether (1.2 mL), and then the solution was 
centrifuged for 5 min. The precipitate was dissolved in 400 μL of H2O:MeCN (1:1) and 
analysed by reversed-phase HPLC-MS. 
tR = 10.9 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z) for C70H116N18O22 calculated 1561.8 [MH]+; found 781.4 [MH2]2+ 
P2-L1 COUPLING: 
P2 resin (0.0084 mmol, 30 mg) was placed in an Eppendorf tube, 240 μl of DMF 
were added along with 0.195 M DIEA in DMF (0.0126 mmol, 64 μl) and HATU (0.0084 
mmol, 3.2 mg). The resulting mixture was mixed for 3 min for its activation, and then L1 
(0.042 mmol, 16.35 mg) was added and the mixture stirred for 1.5 h. Finally, the resin 
was filtered and washed with DCM (2 × 1 mL × 2 min).  
For its HPLC analysis, 3-4 mg of the resin were treated with 150 μL of the cleaving 
cocktail (2.5% triisopropylsilane, TIS, 2.5% H2O, and 95% TFA) for 1.5 h. Then, the resin 
was filtered, the filtrate was placed in ice-cold ether (1.2 mL), and then the solution was 
centrifuged for 5 min. The precipitate was dissolved in 400 μL of H2O:MeCN (1:1) and 
analysed by reversed-phase HPLC-MS. 
Experimental Part 
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tR = 11.6 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
ESI-MS (m/z) for C70H115N19O24 calculated 1606.8 [MH]+; found 804.5 [MH2]2+ 
L2 
 
Compound 1 (0.97 mmol, 500 mg) and 4-nitrobenzylbromide (0.97 mmol, 210 mg) 
were dissolved in ACN (25 mL) and NaHCO3 (3.9 mmol, 326 mg) was added to the 
mixture. The solution was stirred for 14 h under reflux. Then, the solvent was removed 
under reduced pressure and the crude was purified by column chromatography using 
SiO2 with MeOH/CH2Cl2 (5:95) as the mobile phase. 
ESI-MS: m/z (l%) 650.4 (49%) [MH]+, 672.4 (100%) [MNa]+ 
IR: (cm-1) νas(NO2) = 1512 , νs(NO2) = 1345 ν(C=O) = 1712 ν(C-H) = 2932 
Compound 4 (0.31 mmol, 200 mg) was reduced under H2 atmosphere with Pd/C 
catalysis in 10 mL of methanol for 12 h. Then, the solvent was removed under reduced 
pressure obtaining Compound 5 (L2). 
ESI-MS: m/z (l%) 620.4 (70%) [MH]+. 
1H-NMR (400 MHz, CDCl3) δ (ppm): 1.40 (m, 38H), 2.98 (m, 36H), 6.57 (d, 2H, J = 8.9 Hz), 
6.87 (m, 1H), 7.12 (d, 2H, J = 8.7 Hz). 
13C-NMR: (ppm) 173.29, 172.34, 170.55, 169.65, 146.22, 143.97, 130.88, 129.60, 127.36, 
126.29, 115.18, 115.04, 112.50, 82.74, 82.29, 81.66, 81.46, 77.45, 58.86, 57.97, 55.83, 
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55.62, 53.53, 51.16, 49.03, 47.41, 31.83, 29.59, 28.16, 28.13, 27.93, 27.82, 22.60, 20.38, 
14.05.  
P1-L2 COUPLING 
 
P1 resin (0.0084 mmol, 30 mg) was placed in an Eppendorf tube, 250 μl of DMF 
were added along with 0.195 M DIEA in DMF (0.0168 mmol, 86 μl) and HBTU (0.0084 
mmol, 3.2 mg). The resulting mixture was mixed for 3 min for its activation, and then L2 
(0.042 mmol, 26 mg) was added and the mixture stirred for 1.5 h. Finally, the resin was 
filtered and washed with DCM (2 × 1 mL × 2 min). 
For its HPLC analysis, 3-4 mg of the resin were treated with 150 μL of the cleaving 
cocktail (2.5% triisopropylsilane, TIS, 2.5% H2O, and 95% TFA) for 4 h. Then, the resin 
was filtered, the filtrate was placed in ice-cold ether (1.2 mL), and then the solution was 
centrifuged for 5 min. The precipitate was dissolved in 400 μL of H2O/MeCN (1:1) and 
analysed by reversed-phase HPLC-MS. 
tR = 10.9 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
P2-L2 COUPLING 
P2 resin (0.0084 mmol, 30 mg) was placed in an Eppendorf tube, 250 μl of DMF 
were added along with 0.195 M DIEA in DMF (0.0168 mmol, 86 μl) and HBTU (0.0084 
mmol, 3.2 mg). The resulting mixture was mixed for 3 min for its activation, and then L2 
(0.042 mmol, 16.35 mg) was added and the mixture stirred for 1.5 h. Finally, the resin 
was filtered and washed with DCM (2 × 1 mL × 2 min). 
For its HPLC analysis, 3-4 mg of the resin were treated with 150 μL of the cleaving 
cocktail (2.5% triisopropylsilane, TIS, 2.5% H2O, and 95% TFA) for 4 h. Then, the resin 
was filtered, the filtrate was placed in ice-cold ether (1.2 mL), and then the solution was 
centrifuged for 5 min. The precipitate was dissolved in 400 μL of H2O:MeCN (1:1) and 
analysed by reversed-phase HPLC-MS. 
tR = 11.6 min (column Phenomenex Aeris peptide XB-C18, lineal gradient 5→95 % ACN, 
0.1 % TFA / H2O, 0.1 % TFA in 23 min). 
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Conclusions 
This work has focused on the design and synthesis of potential luminescent sensors 
for oxidative stress, based on small peptide units coupled to DO3A units for the 
coordination to a luminescent Eu3+ ion. Our design relies on the lower pKa of the phenol 
group of a tyrosine group upon nitration. Deprotonation of the nitrated peptide is 
expected to cause coordination of the nitrophenyl group to the lanthanide ion, allowing 
the luminescent sensitization of the lanthanide through the antenna effect. The work 
presented in this report focused on the synthesis of the two main components of the 
sensor, peptides P1 and P2, and a DO3A unit functionalized with an amine group. The 
analysis of the experimental results provides the following conclusions: 
• Two DOTA ligand derivatives containing amine were successfully synthesized, 
2,2',2''-(10-(2-aminoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic 
acid (L1) and tri-tert-butyl 2,2',2''-(10-(4-aminobenzyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (L2). 
• Ligand L1 was found to be particularly inefficient in the formation of complexes 
with the Eu3+ ion, suggesting that the presence of the ethylamine arm interferes 
in the complexation process, which was found to be extremely slow. 
• Two peptides derived from α-synuclein (EPGVLYVGSKT and EPGVLnYVGSKT), 
were synthesized by SPPS. One of them contains a nitrated tyrosine residue (nY) 
in order to study the use of this chromophore as lanthanide sensitizer. 
HPLC-MS analysis confirmed that both ligands were coupled to both peptides in the 
carboxylic acid group of the side chain of the Glu residue. However, the coupling 
reaction conditions must be optimized in order to improve the yield of the desired 
products and reduce the formation of the unreactive lacta
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Conclusiones 
Este Trabajo de Fin de Grado se centró en el diseño y síntesis de un potencial sensor 
luminiscente para el estrés oxidativo, basado en pequeños péptidos acoplados a 
unidades DO3A para la coordinación del ion Eu3+. El diseño se sustenta en el menor pKa 
del grupo fenol de un grupo tirosina una vez que sufre un proceso de nitración. La 
desprotonación del péptido nitrado es de esperar que provoque la coordinación del 
grupo cromóforo nitrofenilo al ion lantánido, permitiendo su excitación mediante el 
conocido efecto antena. El trabajo presentado en esta memoria se centró en la síntesis 
de los dos componentes principales del sensor, los péptidos P1 e P2, y la unidad DO3A 
funcionalizada con un grupo amino para su acoplamiento con los péptidos. El análisis de 
los resultados experimentales permitió llegar a las siguientes conclusiones: 
• Dos ligandos derivados del compuesto DOTA, fueron sintetizados con éxito, el 
ácido 2,2',2''-(10-(2-aminoetil)-1,4,7,10-tetraazacyclododecano-1,4,7-
triil)triacetico (L1) y el  tri-tert-butil 2,2',2''-(10-(4-aminobencil)-1,4,7,10-
tetraazacyclododecano-1,4,7-triil)triacetato (L2). 
• El ligando L1 es particularmente ineficiente en la complejación del ion Eu3+, lo 
que sugiere que la presencia del brazo etilamina interfiere de alguna manera en 
el proceso de complejación, que es extraordinariamente lento. 
• Dos péptidos, EPGVLYVGSKT y EPGVLnYVGSKT derivados de α-sinucleína, se 
sintetizaron por SPPS. Uno de ellos contiene un residuo de tirosina nitrado (nY) 
para estudiar el uso de este cromóforo como sensibilizador de lantánidos. 
• Se confirmó por HPLC-MS que ambos ligandos se acoplaron a ambos péptidos en 
el ácido carboxílico de la cadena lateral del residuo de Glu. Sin embargo, las 
condiciones de la reacción de acoplamiento deben optimizarse para mejorar el 
rendimiento de los productos deseados y reducir la formación de las lactamas 
no reactivas. 
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. Conclusións 
Este Traballo de Fin de Grao centrouse no deseño e síntese dun potencial sensor 
luminescente para o estres oxidativo, baseado en pequenos péptidos acoplados a 
unidades DO3A para a coordinación do ion Eu3+. O deseño susténtase no menor pKa do 
grupo fenol dun grupo tirosina unha vez que sofre un proceso de nitración. A 
deprotonación do péptido nitrado é de esperar que provoque a coordinación do grupo 
cromofórico nitrofenilo ao ion lantánido, permitindo a súa excitación mediante o 
coñecido efecto antena. O traballo presentado nesta memoria centrouse na síntese dos 
dous compoñentes principais do sensor, os péptidos P1 e P2, e a unidade DO3A 
funcionalizada cun grupo amino para o seu acoplamento cos péptidos. A análise dos 
resultados experimentais permitiu chegar ás seguintes conclusións: 
• Dous ligandos derivados do DOTA, foron sintetizados con éxito, o ácido 2,2',2''-
(10-(2-aminoetil)-1,4,7,10-tetraazacyclododecano-1,4,7-triil)triacetico (L1) e o  
tri-tert-butil 2,2',2''-(10-(4-aminobencil)-1,4,7,10-tetraazacyclododecano-1,4,7-
triil)triacetato (L2). 
• O ligando L1 é particularmente ineficiente na complexación do ion Eu3+, o que 
suxire que a presenza do brazo etilamina interfire dalgunha maneira no proceso 
de complexación, que é extraordinariamente lento. 
• Dous péptidos, EPGVLYVGSKT e EPGVLnYVGSKT derivados de α-sinucleina, foron 
sintetizados mediante SPPS. Un deles contén un residuo de tirosina nitratado 
(nY) para estudar o uso deste cromóforo como un sensibilizador de lantánidos. 
• Confirmouse por HPLC-MS que ambos ligandos foron acoplados a ambos 
péptidos no ácido carboxílico da cadea lateral do residuo de Glu. Non obstante, 
as condicións da reacción do acoplamento deben optimizarse para mellorar o 
rendemento dos produtos desexados e reducir a formación das lactamas non 
reactivas. 
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Annex 
COMPOUND 2 
 
COMPOUND 3, L1 
 
 
 +TOF MS: 0.933 to 1.016 min from Sample 2 (FF1A, MeOH) of 2018_05976_FF1A_esitof_pos_01.wiff
a=3.60109381860458080e-004, t0=-1.68289587902022470e+001 R; (Turbo Spray)
Max. 1722.8 counts.
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m/z, Da
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
65%
70%
75%
80%
85%
90%
95%
100%
R
e
l.
 I
n
t.
 (
%
)
658.48
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515.38
680.46
413.27
301.14157.08 393.30
218.15 239.09 436.91
196.17 335.13 459.3272.94 720.40602.41130.16 403.26 559.13257.14245.08 271.18 633.15 758.22 844.94 942.89866.92 1018.94832.24
 +TOF MS: 0.766 to 0.866 min from Sample 2 (FF1B-4, MeOH) of 2018_07348_FF1B-4_esitof_pos_01.wiff
a=3.60119144309961060e-004, t0=-1.65378539493322060e+001 R; (Turbo Spray)
Max. 2174.9 counts.
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390.23
428.18
58.96
446.30135.09 152.95
75.01
412.21
214.59149.02 301.1484.01 450.16 485.11
559.13418.88335.13259.01 684.20157.0898.97 198.18 273.17 580.1264.93 758.22502.14 696.85403.13 832.24622.03 858.09 906.26490.27 962.78796.88
   
 
 
64 
 
 
 
 65 
 
P1-L1 
 
 
P2-L1 
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COMPOUND 4 
 
 
  
 +TOF MS: 0.283 to 0.433 min from Sample 3 (Agimix) of 2018_23883_FFSA_esitof_pos_01.wiff
a=3.60114632902097460e-004, t0=-1.71468088333021420e+001 R; (Turbo Spray)
Max. 1449.4 counts.
100 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600
m/z, Da
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672.39
135.09
650.41
157.08 413.27
301.14
74.06 393.30218.15 239.09149.02
482.22 594.35335.13129.05 229.14 538.29 616.33712.33430.91 802.3598.98 822.90 906.25 980.92 1208.861056.89 1290.91 1332.901398.88
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COMPOUND 5 
 
 
 
 
 
 +TOF MS: 0.017 to 0.117 min from Sample 3 (Agimix) of 2018_26199_FFSB-3_esitof_pos_01.wiff
a=3.60115611104772570e-004, t0=-1.71132168631297930e+001 R; (Turbo Spray)
Max. 1292.1 counts.
50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900 950 1000 1050 1100 1150 1200 1250
m/z, Da
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620.44
515.38
135.09
642.42
459.32
403.25
157.08
413.27301.1460.08 347.19273.17 553.33218.15 537.36
130.16 634.45 664.46335.1356.96 485.11350.99 411.09 844.94748.96 882.95764.17 1108.901082.951002.95 1139.92
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